Calming restless legs

Sleep

Volumn 27, Issue 5, 2004, Pages 839-841

  Silber, Michael H ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CARBIDOPA PLUS LEVODOPA; DEXTROPROPOXYPHENE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ERGOT DERIVATIVE; GABAPENTIN; OPIATE; PRAMIPEXOLE; ROPINIROLE;

CLINICAL RESEARCH; CLINICAL TRIAL; DISEASE CLASSIFICATION; DIZZINESS; DRUG EFFICACY; EDEMA; EDITORIAL; HUMAN; HYPERSOMNIA; NAUSEA; NOSE OBSTRUCTION; PRIORITY JOURNAL; RATING SCALE; RESTLESS LEGS SYNDROME; SLEEP; SOMNOLENCE; TREATMENT INDICATION;

ANALGESICS, OPIOID; ANTIPARKINSON AGENTS; BENZOTHIAZOLES; DOPAMINE AGONISTS; HUMANS; INDOLES; NOCTURNAL MYOCLONUS SYNDROME; RESTLESS LEGS SYNDROME; THIAZOLES; WAKEFULNESS;

EID: 4143094844     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (35)

1. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Int Med 2000; 160:2137-2141.
2. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and morbidity in Augsburg elderly. Neurology 2000; 54:1064-1068.
3. Nichols DA, Allen RP, Grauke JH, et al. Restless legs syndrome symptoms in primary care. A prevalence study. Arch Intern Med 2003; 163:2323-2329.
4. Lavigne GJ, Montplaisir JY. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1994; 17:739-43.
5. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of health. Sleep Med 2003; 4:101-119.
6. Allen R et al. Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome. SLEEP 2004; 27(5):907-14.
7. Adler CH, Hauser RA, Sethi K, et al. Ropinirole for restless legs syndrome - A placebo-controlled crossover trial. Neurology 2004; 62:1405-1407.
8. Trenkwalder C, Garcia-Borreguero D, Montagna P, et al. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 2004; 75:92-97.
9. Hening W, Allen R, Earley C, Kushida C, Picchietti D, Silber M. The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Review. Sleep 1999; 22:970-99.
10. Chesson AL, Jr., Wise M, Davila D, et al. Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 1999; 22:961-8.
11. Littner MR, Kushida C, Anderson WM, et al.. Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep 2004; 27:557-559.
12. Hening W, Allen R, Earley C, et al. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine review. Sleep 2004; 27:560-583.
13. Silber MH, Ehrenberg BL, Allen RP. An algorithm for the management of restless legs syndrome. Mayo Clin Proc 2004;79:916-922.
14. Silber M, Richardson JW. Multiple blood donations associated with iron deficiency in patients with restless legs syndrome. Mayo Clin Proc 2003; 78:52-54.
15. Ulfberg J, Nystrom B. Restless legs syndrome in blood donors. Sleep Med 2004; 2:115-118.
16. Kryger MH, Shepertycki M, Foerster J, Manfreda J. Seep disorders in repeat blood donors. Sleep 2003; 26:625-626.
17. Sun ER, Chen CA, Ho G, Barley CJ, Allen RP. Iron and the restless legs syndrome. Sleep 1998; 21:371-7.
18. O'Keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing 1994; 23:200-3.
19. Trenkwalder C, Stiasny K, Pollmacher T, et al. L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial. Sleep 1995; 18:681-8.
20. Collado-Seidel V, Kazenwadel J, Wetter TC, et al. A controlled study of additional sr-L-dopa in L-dopa-responsive restless legs syndrome with late-night symptoms. Neurology 1999; 52:285-90.
21. Allen RP, Barley CJ. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 1996; 19:205-13.
22. Wetter TC, Stiasny K, Winkelmann J et al., et al. A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology 1999; 5:944-950.
23. Silber MH, Shepard JW, Jr., Wisbey JA. Pergolide in the management of restless legs syndrome: an extended study. Sleep 1997; 20:878-82.
24. Barley CJ, Yaffee JB, Allen RP. Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome. Neurology 1998; 51:1599-602.
25. Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B. Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology 1999; 52:938-43.
26. Montplaisir J, Denesle R, Petit D. Pramipexole in the treatment of restless legs syndrome: a follow-up study. Eur J Neurol 2000; 7:27-31.
27. Silber M, Girish M, Izurieta R. Pramipexole in the management of restless legs syndrome: an extended study. Sleep 2003; 26:819-821.
28. Winkelman JW, Johnston L. Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS). Sleep Med 2004; 5:9-14.
29. Stiasny K, Moller JC, Oertel WH. Safety of pramipexole in patients with restless legs syndrome. Neurology 2000; 55:1589-90.
30. Danoff SK, Grasso ME, Terry PB, Flynn JA. Pleuropulmonary disease due to pergolide use for restless legs syndrome. Chest 2001; 120:313-6.
31. Pritchett A, Morrison JF, Edwards WD, Schaff HV, Connolly HM, Espinosa EE. Valvular heart disease in patients taking pergolide. Mayo Clin Proc 2002; 77:1280-1286.
32. Garcia-Borreguero D, Larrosa E, De la Llave Y, Verger K, Masramon X, Hernandez G. Treatment of restless legs syndrome with gabapentin. A double-blind, cross-over study. Neurology 2002; 59:1573-1579.
33. Walters AS, Wagner ML, Hening WA, et al. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep 1993; 16:327-32.
34. Walters AS, Winkelmann J, Trenkwalder C, et al. Long-term follow-up on restless legs syndrome patients treated with opioids. Mov Dis 2001; 16:1105-1109.
35. Matthews WB. Treatment of the restless legs syndrome with clonazepam. Br Med J 1979; 1:751.